HEAL Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Publication Selector by Date
October | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
4
|
|||
5
|
6
|
8
|
9
|
10
|
11
|
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
31
|
February | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
6
|
7
|
|||
8
|
9
|
13
|
14
|
|||
15
|
16
|
20
|
21
|
|||
22
|
23
|
27
|
28
|
March | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
13
|
14
|
|||
15
|
16
|
20
|
21
|
|||
22
|
23
|
27
|
28
|
|||
29
|
30
|
April | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
3
|
4
|
||||
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
21
|
23
|
24
|
25
|
||
26
|
29
|
30
|
May | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
|||||
3
|
4
|
6
|
7
|
8
|
9
|
|
10
|
11
|
12
|
15
|
16
|
||
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
29
|
30
|
|
31
|
June | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
5
|
6
|
||
7
|
8
|
10
|
12
|
13
|
||
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
July | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
4
|
|||
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
August | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
||||||
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
September | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
4
|
5
|
||
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
October | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
||||
4
|
5
|
6
|
7
|
9
|
10
|
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
21
|
23
|
24
|
||
25
|
26
|
30
|
31
|
February | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
3
|
5
|
6
|
|||
7
|
8
|
10
|
12
|
13
|
||
14
|
15
|
16
|
19
|
20
|
||
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
March | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
3
|
5
|
6
|
|||
7
|
8
|
10
|
12
|
13
|
||
14
|
15
|
19
|
20
|
|||
21
|
22
|
25
|
26
|
27
|
||
28
|
29
|
30
|
31
|
April | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
||||
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
16
|
17
|
|||
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
MINUTES OF PROCEEDING
(Meeting No. 19 )
Wednesday, February 18, 1998
The Standing Committee on Health met at 3:33 o’clock p.m., this day, in
room 705 , La Promenade Bldg., the Chair, Beth Phinney, presiding.
Members of the Committee present: Elinor Caplan, Aileen Carroll, Claude Drouin, Grant Hill, Lynn Myers, Pauline Picard, Rose-Marie Ur, Joseph Volpe, Judy Wasylycia-Leis.
In attendance: From the Research Branch of the Library of Parliament: Odette Madore, Nancy Miller-Chenier and Gérald Lafrenière, Research Officers.
Pursuant to Standing Order 108(2), the Committee resumed consideration of natural health products. (See Minutes of Proceedings dated Thursday, November 20, 1997.)
Witnesses: From the Nonprescription Drug Manufacturers Association: David Skinner, President; Dr. Natalie Lazarowych, Technical Director, Ashbury Biologicals Inc.; Bendra Watson. From the Canadian Association of Chain Drug Stores: Ellen Mary Mills, Vice President, Policy and Public Affairs; Phil Rosenberg, Director, Pharmacy Operations, Hy & Zel’s Inc., Thornhill, Ontario; Sandra Aylward, Director, Pharmacy Affairs, Lawtons Drug Stores Ltd., Dartmouth, Nova Scotia. From the National Association for Health Products: André Gagnon, Spokesperson; André Aubé, Pharmacist & President, Regulatory Framework Committee; Michel Sasseville, Biochemist & Member of the Board; Pierre Morin, Counsellor.
David Skinner, Ellen Mary Mills and André Gagnon made opening statements and, with the other witnesses, answered questions.
At 5:20 o’clock p.m., the Committee adjourned to the call of the Chair.
ROGER PRÉFONTAINE
Clerk of the Committee